Haemonetics Restructures Financial Reporting to Two Segments

Haemonetics Corporation announced a change to its financial reporting segment structure, effective with the first quarter of fiscal year 2027. The company will transition from three to two reportable segments, combining the Plasma and Blood Center segments into a new 'Apheresis' segment and renaming the Hospital segment to 'MedSurg'. This restructuring aims to better align external financial reporting with how the company manages its business and allocates resources. A supplemental presentation with recast historical financial data and fiscal year 2027 guidance has been posted for comparability.